Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19 | Zendy

Raymond T. Suhandynata | Zendy; Melissa Hoffman | Zendy; Michael J. Kelner | Zendy; Ronald W. McLawhon | Zendy; Sharon L. Reed | Zendy; Robert L. Fitzgerald | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19

Author(s) -

Raymond T. Suhandynata,

Melissa Hoffman,

Michael J. Kelner,

Ronald W. McLawhon,

Sharon L. Reed,

Robert L. Fitzgerald

Publication year - 2020

Publication title -

the journal of applied laboratory medicine

Language(s) - English

Resource type - Journals

eISSN - 2576-9456

pISSN - 2475-7241

DOI - 10.1093/jalm/jfaa139

Subject(s) - serology , medicine , covid-19 , virology , roche diagnostics , coronavirus , predictive value , antibody , immunology , immunoglobulin m , immunoglobulin g , infectious disease (medical specialty) , disease

COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel beta-coronavirus that is responsible for the 2019 coronavirus pandemic. Acute infections should be diagnosed by polymerase chain reaction (PCR) based tests, but serology tests can demonstrate previous exposure to the virus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research